Biological Safety Cabinet Market Size, COVID-19 Impact Analysis, Regional Outlook, Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2022 – 2028

Biological Safety Cabinet Market Size is expected to register commendable growth between 2022 and 2028. Biosafety cabinets constitute ventilated enclosures that offer protection to the user, the environment, and products against aerosols that arise from the handling of potentially hazardous micro-organisms. The systems discharge air flow to the atmosphere by means of a HEPA filter. Multiple benefits offered by biological safety cabinets comprise product protection for avoiding the contamination of samples and personal protection from harmful agents within the cabinet.
 

On the basis of type, the class II segment is anticipated to account for a substantial share in the biological safety cabinet industry through the estimated period. The surging revenue is attributed to the rising product usage for handling pathogenic biological samples. These cabinets are also used for applications where a sterile work zone is mandatory.
 

Prominent features of class II systems include an ULPA/HEPA-filtered exhaust for the protection of the environment and an ULPA/HEPA-filtered downflow that generates an ISO Class 3 work surface that leads to the prevention of cross contamination.
 

Based on end-use, the pharmaceutical & biopharmaceutical companies segment is estimated to account for a lucrative share in the biological safety cabinet market through 2028. Numerous companies are preferring biosafety cabinets owing to the critical nature of laboratory work and for operating within a performance envelope that provides the most extensive margin of product penetration and safety for the most demanding laboratory conditions.
 

The segment expansion can also be credited to the extensive deployment of safety cabinets for meeting a diverse range of applications across the life science, pharmaceutical, and clinical sectors.
 

Considering the regional landscape, the North America biological safety cabinet market value is expected to record commendable growth over the estimated period. This growth is propelled by an increase in regulatory initiatives for enhancing product developments. For instance, the CDC has started an online course on the safe use of Class II biological safety cabinets for safety professionals, clinical laboratory and public health staff, and persons interested in the safe usage of the equipment. Similar initiatives are set to establish a strong foothold for regional growth over the coming years.
 

Leading companies in the biological safety cabinet market include Thermo Fisher Scientific, Inc., Germfree Laboratories, BIOBASE, NuAire, EUROCLONE, Cruma Air Science, Kewaunee Scientific, Esco Micro, Berner International, and others. These players are taking a keen interest in the implementation of strategic initiatives such as mergers, acquisitions, product developments, partnerships, and collaborations for maintaining their position in the market.
 

For instance, in May 2021, Labconco, one of the key biological safety cabinet manufacturers, rolled out its newly updated Purifier Axiom Biosafety Cabinet. The product launch continues the company’s commitment towards keeping researchers efficient and safe in the pursuit of science.
 

Impact of COVID-19 pandemic on biological safety cabinet market outlook

The SARS-CoV-2 pandemic has led to an increase in regulatory recommendations for ensuring biosafety levels for individuals working in laboratories. For instance, as per the CDC, clinical laboratories handling patient samples including urine practice standard precautions, blood (and blood constituents), and respiratory specimens. The rising issuance of laboratory biosafety guidelines from regulators, including the World Health Organization, is set to propel the demand for biological safety cabinets across various regions.
 

The biological safety cabinet market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2028 for the following segments:

Market, by Product Type

• Class I
• Class II
• Class III

Market, by End-use

• Pharmaceutical & Biopharmaceutical Companies
• Diagnostic & Testing Laboratories
• Academic & Research Institutes

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Mexico
  • Brazil
• Middle East and Africa
  • Saudi Arabia
  • South Africa

What Information does this report contain?